Key result
Higher monocyte to HDL cholesterol ratio was an independent predictor of high intracoronary thrombus burden in patients with STEMI undergoing primary PCI (OR 1.067; 95% CI 1.031-1.105; P<.001).
Why the study?
Does the monocyte to HDL cholesterol ratio predict high intracoronary thrombus burden in patients with STEMI undergoing primary PCI?
Population
414 patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary…
Comparison
High monocyte to HDL cholesterol ratio (MHR) vs Low monocyte to HDL cholesterol ratio (MHR)
Design
Cohort
Authors
Loading...
MHR may identify STEMI patients at higher thrombus risk during PCI; hypothesis-generating and should not yet change practice.
Observational (n=414)
Does the monocyte to HDL cholesterol ratio predict high intracoronary thrombus burden in patients with STEMI undergoing primary PCI?
Odds Ratio: 1.067 (95% CI 1.031–1.105)
p-value: p=< .001
The monocyte to HDL cholesterol ratio is an independent predictor of high angiographic thrombus burden in STEMI patients undergoing primary PCI, potentially aiding in risk stratification.
Arısoy et al. (2016) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=414). Monocyte to HDL cholesterol ratio (MHR) was evaluated on High intracoronary thrombus burden (OR 1.067, 95% CI 1.031-1.105, p=< .001). Higher monocyte to HDL cholesterol ratio was an independent predictor of high intracoronary thrombus burden in patients with STEMI undergoing primary PCI (OR 1.067; 95% CI 1.031-1.105; P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: